Can-Fite Biopharma Ltd (CANF)

AMEX

$3.32

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. The company is headquartered in Petah-Tikva, Israel.

Website: https://www.canfite.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $8 (+140.96%)

Market Cap

$6.87M

Beta (5Y)

0.79

Price Chart

Adjust inflation

Log

Valuation

Market Cap$6.87M

Forward P/E2.97

P/S17.56

P/B1.26

Profitability

Total Revenue (TTM)$405K

Gross Profit (TTM)$405K

EBITDA-$9.93M

Operating Margin-2489%

EPS-$2.76

Financial Health

Debt-to-Equity1.3%

Growth & Risk

Revenue 5Y CAGR-11.90%

FCF 5Y CAGR-3.13%

Beta (5Y)0.79

Sharpe Ratio-1.34